Monoclonal B cell lymphocytosis and "in situ" lymphoma

Seminars in Cancer Biology

Volumn 24, Issue , 2014, Pages 3-14

  Karube, Kennosuke ^a   Scarfò, Lydia ^b   Campo, Elias ^a   Ghia, Paolo ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Chronic lymphocytic leukemia; Follicular lymphoma; In situ lymphoma; Mantle cell lymphoma; Monoclonal B cell lymphocytosis; T(11; 14)(q13; q32); T(14; 18)(q32; q21)

Indexed keywords

B LYMPHOCYTE; CANCER GROWTH; CARCINOGENESIS; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; GENE MUTATION; GERMINAL CENTER; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU FOLLICULAR LYMPHOMA; IN SITU LYMPHOMA; IN SITU MANTLE CELL LYMPHOMA; LEUKEMOGENESIS; LYMPHOCYTE COUNT; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MOLECULAR PATHOLOGY; MONOCLONAL B CELL LYMPHOCYTOSIS; NONHUMAN; REVIEW;

CHRONIC LYMPHOCYTIC LEUKEMIA; FOLLICULAR LYMPHOMA; IN SITU LYMPHOMA; MANTLE CELL LYMPHOMA; MONOCLONAL B CELL LYMPHOCYTOSIS; T(11;14)(Q13;Q32); T(14;18)(Q32;Q21);

B-LYMPHOCYTES; CELL LINEAGE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; TRANSLOCATION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 84892836847     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.08.003     Document Type: Review

References (103)

1. Kyle R.A., Therneau T.M., Rajkumar S.V., Larson D.R., Plevak M.F., Offord J.R., et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006, 354:1362-1369.
2. Marti G.E., Rawstron A.C., Ghia P., Hillmen P., Houlston R.S., Kay N., et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005, 130:325-332.
3. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H., et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008, 111:5446-5456.
4. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996, 87:4990-4997.
5. Shanafelt T.D., Ghia P., Lanasa M.C., Landgren O., Rawstron A.C. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010, 24:512-520.
6. Fernandez V., Salamero O., Espinet B., Sole F., Royo C., Navarro A., et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 2010, 70:1408-1418.
7. Navarro A., Clot G., Royo C., Jares P., Hadzidimitriou A., Agathangelidis A., et al. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 2012, 72:5307-5316.
8. Marti G.E., Shim Y.K., Albitar M., Middleton D., Abbasi F., Anderson A., et al. Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. Cytometry B: Clin Cytom 2010, 78(Suppl. 1):S83-S90.
9. Rachel J.M., Zucker M.L., Fox C.M., Plapp F.V., Menitove J.E., Abbasi F., et al. Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol 2007, 139:832-836.
10. Rawstron A.C., Green M.J., Kuzmicki A., Kennedy B., Fenton J.A., Evans P.A., et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002, 100:635-639.
11. Ghia P., Prato G., Scielzo C., Stella S., Geuna M., Guida G., et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004, 103:2337-2342.
12. Dagklis A., Fazi C., Sala C., Cantarelli V., Scielzo C., Massacane R., et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 2009, 114:26-32.
13. Fazi C., Scarfo L., Pecciarini L., Cottini F., Dagklis A., Janus A., et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. Blood 2011, 118:6618-6625.
14. Nieto W.G., Almeida J., Romero A., Teodosio C., Lopez A., Henriques A.F., et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009, 114:33-37.
15. Scarfo L., Dagklis A., Scielzo C., Fazi C., Ghia P. CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it. Semin Cancer Biol 2010, 20:384-390.
16. Almeida J., Nieto W.G., Teodosio C., Pedreira C.E., Lopez A., Fernandez-Navarro P., et al. CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. Leukemia 2011, 25:718-722.
17. Rawstron A.C., Yuille M.R., Fuller J., Cullen M., Kennedy B., Richards S.J., et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002, 100:2289-2290.
18. de Tute R., Yuille M., Catovsky D., Houlston R.S., Hillmen P., Rawstron A.C. Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia 2006, 20:728-729.
19. Rawstron A.C., Shanafelt T., Lanasa M.C., Landgren O., Hanson C., Orfao A., et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B: Clin Cytom 2010, 78(Suppl. 1):S19-S23.
20. Rawstron A.C., Bennett F.L., O'Connor S.J., Kwok M., Fenton J.A., Plummer M., et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008, 359:575-583.
21. Shanafelt T.D., Kay N.E., Rabe K.G., Call T.G., Zent C.S., Maddocks K., et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009, 27:3959-3963.
22. Shanafelt T.D., Kay N.E., Jenkins G., Call T.G., Zent C.S., Jelinek D.F., et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009, 113:4188-4196.
23. Fung S.S., Hillier K.L., Leger C.S., Sandhu I., Vickars L.M., Galbraith P.F., et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma 2007, 48:1087-1091.
24. Mulligan C.S., Thomas M.E., Mulligan S.P. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008, 359:2065-2066. author reply 2066.
25. Scarfo L., Zibellini S., Tedeschi A., Maura F., Neri A., Bertazzoni P., et al. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines. Leukemia 2012, 26:1703-1707.
26. Landgren O., Albitar M., Ma W., Abbasi F., Hayes R.B., Ghia P., et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009, 360:659-667.
27. Schroeder H.W., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994, 15:288-294.
28. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-1525.
29. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
30. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
31. Stamatopoulos K., Belessi C., Moreno C., Boudjograh M., Guida G., Smilevska T., et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007, 109:259-270.
32. Agathangelidis A., Darzentas N., Hadzidimitriou A., Brochet X., Murray F., Yan X.J., et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012, 119:4467-4475.
33. Vardi A., Dagklis A., Scarfo L., Jelinek D., Newton D., Bennett F., et al. Immunogenetics shows that not all MBL are equal: the larger the clone the more similar to CLL. Blood 2013, 121:4521-4528.
34. Colombatti A., Doliana R., Schiappacassi M., Argentini C., Tonutti E., Feruglio C., et al. Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences. Clin Immunol Immunopathol 1998, 89:61-70.
35. Ghia P., Prato G., Stella S., Scielzo C., Geuna M., Caligaris-Cappio F. Age-dependent accumulation of monoclonal CD4+CD8+ double positive T lymphocytes in the peripheral blood of the elderly. Br J Haematol 2007, 139:780-790.
36. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169:1984-1992.
37. Fazi C., Dagklis A., Cottini F., Scarfo L., Bertilaccio M.T., Finazzi R., et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B: Clin Cytom 2010, 78(Suppl. 1):S61-S68.
38. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916.
39. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T., et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010, 17:28-40.
40. Puente X.S., Pinyol M., Quesada V., Conde L., Ordonez G.R., Villamor N., et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011, 475:101-105.
41. Rossi D., Rasi S., Fabbri G., Spina V., Fangazio M., Forconi F., et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012, 119:521-529.
42. Wang L., Lawrence M.S., Wan Y., Stojanov P., Sougnez C., Stevenson K., et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011, 365:2497-2506.
43. Quesada V., Conde L., Villamor N., Ordonez G.R., Jares P., Bassaganyas L., et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012, 44:47-52.
44. Rossi D., Fangazio M., Rasi S., Vaisitti T., Monti S., Cresta S., et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 2012, 119:2854-2862.
45. Rasi S., Monti S., Spina V., Foa R., Gaidano G., Rossi D. Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis. Haematologica 2012, 97:153-154.
46. Greco M., Capello D., Bruscaggin A., Spina V., Rasi S., Monti S., et al. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. Hematol Oncol 2013, 31:54-55.
47. Tsimberidou A.M., Wen S., O'Brien S., McLaughlin P., Wierda W.G., Ferrajoli A., et al. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. J Clin Oncol 2007, 25:4648-4656.
48. Armitage J.O., Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998, 16:2780-2795.
49. Caligaris-Cappio F., Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease. J Clin Oncol 2008, 26:4497-4503.
50. Granziero L., Ghia P., Circosta P., Gottardi D., Strola G., Geuna M., et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001, 97:2777-2783.
51. Calissano C., Damle R.N., Hayes G., Murphy E.J., Hellerstein M.K., Moreno C., et al. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia. Blood 2009, 114:4832-4842.
52. Herishanu Y., Perez-Galan P., Liu D., Biancotto A., Pittaluga S., Vire B., et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011, 117:563-574.
53. Gibson S.E., Swerdlow S.H., Ferry J.A., Surti U., Dal Cin P., Harris N.L., et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 2011, 96:1144-1152.
54. Ghia P. Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis. Haematologica 2011, 96:1089-1091.
55. Rossi D., Sozzi E., Puma A., De Paoli L., Rasi S., Spina V., et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009, 146:64-75.
56. Molica S., Mauro F.R., Giannarelli D., Lauria F., Cortelezzi A., Brugiatelli M., et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica 2011, 96:277-283.
57. Shanafelt T.D., Kay N.E., Rabe K.G., Call T.G., Zent C.S., Schwager S.M., et al. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population. Leukemia 2012, 26:373-376.
58. Nieto W.G., Teodosio C., Lopez A., Rodriguez-Caballero A., Romero A., Barcena P., et al. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics. Cytometry B: Clin Cytom 2010, 78(Suppl. 1):S24-S34.
59. Amato D., Oscier D.G., Davis Z., Mould S., Zheng J., Kolomietz E., et al. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis. Am J Clin Pathol 2007, 128:333-338.
60. Sole F., Woessner S., Florensa L., Espinet B., Mollejo M., Martin P., et al. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol 1997, 98:446-449.
61. Xochelli A., Baliakas P., Gardiner A., Mould S., Davies Z., McIver-Brown N., et al. Monoclonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with marginal zone origin: what is this entityα. Blood 2012, 120. abstr 1587.
62. Bikos V., Darzentas N., Hadzidimitriou A., Davis Z., Hockley S., Traverse-Glehen A., et al. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 2012, 26:1638-1646.
63. Carvajal-Cuenca A., Sua L.F., Silva N.M., Pittaluga S., Royo C., Song J.Y., et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 2012, 97:270-278.
64. Cong P., Raffeld M., Teruya-Feldstein J., Sorbara L., Pittaluga S., Jaffe E.S. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 2002, 99:3376-3382.
65. Swerdlow S., Campo E., Harris N., Jaffe E., Pileri S., Stein H., et al. World Health Organization Classification of Tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues 2009, IARC Press, Lyon. 4th ed.
66. Tsai A.G., Lu H., Raghavan S.C., Muschen M., Hsieh C.L., Lieber M.R. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 2008, 135:1130-1142.
67. Rabkin C.S., Hirt C., Janz S., Dolken G. t(14;18) translocations and risk of follicular lymphoma. J Natl Cancer Inst Monogr 2008, 2008:48-51.
68. Roulland S., Lebailly P., Lecluse Y., Heutte N., Nadel B., Gauduchon P. Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia 2006, 20:158-162.
69. Roulland S., Lebailly P., Lecluse Y., Briand M., Pottier D., Gauduchon P. Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 2004, 64:2264-2269.
70. Schuler F., Hirt C., Dolken G. Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol 2003, 13:203-209.
71. Dolken G., Illerhaus G., Hirt C., Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 1996, 14:1333-1344.
72. Limpens J., Stad R., Vos C., de Vlaam C., de Jong D., van Ommen G.J., et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995, 85:2528-2536.
73. Roulland S., Navarro J.M., Grenot P., Milili M., Agopian J., Montpellier B., et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 2006, 203:2425-2431.
74. Henopp T., Quintanilla-Martinez L., Fend F., Adam P. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 2011, 59:139-142.
75. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S., et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991, 88:8661-8665.
76. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger U., McKearn J.P., et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989, 57:79-88.
77. Sakai T., Nishikori M., Tashima M., Yamamoto R., Kitawaki T., Takaori-Kondo A., et al. Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type. Cancer Sci 2009, 100:2361-2367.
78. Jegalian A.G., Eberle F.C., Pack S.D., Mirvis M., Raffeld M., Pittaluga S., et al. Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood 2011, 118:2976-2984.
79. Montes-Moreno S., Castro Y., Rodriguez-Pinilla S.M., Garcia J.F., Mollejo M., Castillo M.E., et al. Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases. Histopathology 2010, 56:658-662.
80. Bonzheim I., Salaverria I., Haake A., Gastl G., Adam P., Siebert R., et al. A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma. Blood 2011, 118:3442-3444.
81. Carbone A., Santoro A. How I treat: diagnosing and managing "in situ" lymphoma. Blood 2011, 117:3954-3960.
82. Handa T., Maki K., Segawa A., Masawa N., Mitani K. In situ follicular lymphoma associated with progressive transformation of germinal centers. Int J Surg Pathol 2011, 19:521-523.
83. Li J.N., Zhang W.Y., Tang Y., Li G.D., Dong D.D. In situ follicular lymphoma with progressive transformation of the germinal centers confirmed by laser capture microdissection, IGH gene rearrangement analysis, and fluorescence in situ hybridization for t(14;18). Hum Pathol 2012, 43:138-143.
84. Adam P., Katzenberger T., Eifert M., Ott M.M., Rosenwald A., Muller-Hermelink H.K., et al. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol 2005, 29:1661-1664.
85. Carvajal-Cuenca A., Campo E. Early neoplastic lymphoid lesions. Sem Diag Pathol 2013, 30:146-155.
86. Sakhadeo U., Mane A., Shet T. In situ follicular neoplasia/lymphoma: three illustrative cases exemplifying unique disease presentations. Indian J Pathol Microbiol 2012, 55:218-221.
87. Fend F., Cabecadas J., Gaulard P., Jaffe E., Kluin P., Kuzu I., et al. Early lesions in lymphoid neoplasia. J Hematopathol 2012, 5:169-199.
88. Carbone A., Gloghini A. Coexisting follicular and mantle cell lymphoma with each having an in situ component. Am J Clin Pathol 2011, 136:481-483.
89. Carbone A., Della Libera D., Zannier L., Selva A., Ceolin P., Gualeni A., et al. In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node. Am J Hematol 2011, 86:E66-E70.
90. Carbone A., Tibiletti M.G., Canzonieri V., Rossi D., Perin T., Bernasconi B., et al. In situ follicular lymphoma associated with nonlymphoid malignancies. Leuk Lymphoma 2011, 53:603-608.
91. Greisman H.A., Lu Z., Tsai A.G., Greiner T.C., Yi H.S., Lieber M.R. IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas. Blood 2012, 120:2864-2867.
92. Nodit L., Bahler D.W., Jacobs S.A., Locker J., Swerdlow S.H. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol 2003, 34:1030-1034.
93. Espinet B., Sole F., Pedro C., Garcia M., Bellosillo B., Salido M., et al. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma. Hum Pathol 2005, 36:1232-1237.
94. Lecluse Y., Lebailly P., Roulland S., Gac A.C., Nadel B., Gauduchon P. t(11;14)-Positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 2009, 23:1190-1193.
95. Adam P., Schiefer A.I., Prill S., Henopp T., Quintanilla-Martinez L., Bosmuller H.C., et al. Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues. Mod Pathol 2012, 25:1629-1636.
96. Christian B., Zhao W., Hamadani M., Sotomayor E.M., Navarro W., Devine S.M., et al. Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor. J Clin Oncol 2010, 28:e629-e632.
97. Bodrug S.E., Warner B.J., Bath M.L., Lindeman G.J., Harris A.W., Adams J.M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994, 13:2124-2130.
98. Racke F., Simpson S., Christian B., Blum K., Hasserjian R., Zhao W. Evidence of long latency periods prior to development of mantle cell lymphoma. Blood 2010, 116:2384.
99. Edlefsen K.L., Greisman H.A., Yi H.S., Mantei K.M., Fromm J.R. Early lymph node involvement by mantle cell lymphoma limited to the germinal center: report of a case with a novel "follicular in situ" growth pattern. Am J Clin Pathol 2011, 136:276-281.
100. Aqel N., Barker F., Patel K., Naresh K.N. In-situ mantle cell lymphoma - a report of two cases. Histopathology 2008, 52:256-260.
101. Vegliante M.C., Palomero J., Perez-Galan P., Roue G., Castellano G., Navarro A., et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood 2013, 121:2175-2185.
102. Royo C., Navarro A., Clot G., Salaverria I., Gine E., Jares P., et al. Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia 2012, 26:1895-1898.
103. Koletsa T., Markou K., Ouzounidou S., Tsiompanou F., Karkavelas G., Kostopoulos I. In situ mantle cell lymphoma in the nasopharynx. Head Neck 2013, in press.